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ABSTRACT
Koi herpesvirus (KHV) is one of the major pathogen for koi and common carp causing high mortality and
economic losses for the farmers. The purpose of this study was to determine the efficacy of glycoprotein-
11 (GP-11) KHV DNA vaccine and compared to GP-25 KHV DNA vaccine. The vaccine in the form of naked
DNA plasmid was delivered by intramuscularly injection to the three-month-old koi. The fish were divided
into six groups, i.e. unvaccinated group (negative control C- and positive control C+), and vaccinated group
(2.5 g/100 L of GP-11 (group 1), 7.5 g/100 L of GP-11 (group 2), 12.5 g/100 L of GP-11 (group 3),
and 12.5 g/100 L of GP-25 (group 4)). At day 42 post vaccination, all fish of each group were challenged
by injecting KHV titre 10-3 FID50. Number of dead fish was counted everyday after the challenge until 30
days. The results showed that vaccinated fish had survival rate of 83.33%-93.33% (group 2, 3, and 4). It
showed that GP-11 KHV DNA vaccine had high efficacy. As a conclusion, the application of 7.5 g/100 L
of GP-11 DNA vaccines have an equal efficacy with 12.5 g/100 L GP-25 related to the immune response
activity against KHV infection.
KEYWORDS: Cyprinus carpio koi; DNA vaccine; injection; koi herpesvirus
#  Correspondence: Department of Aquaculture, Faculty of
Fisheries and Marine Science, Bogor Agricultural University,
Jl. Agatis, kampus IPB Dramaga, Bogor 16680, Indonesia.
Phone: + (0251) 8628755
E-mail:  sri.nuryati606@gmail.com
INTRODUCTION
Koi herpesvirus (KHV) is considered one of the
most important pathogen in koi and common carp.
The virus consists of double-stranded DNA (ds) which
has been assigned to the family Alloherpesviridae within
the order Herpesvirales (Davison, 2010). The virions
are enveloped with icosahedral capside diameter
100-110 nm with 295-kb linear ds DNA KHV genome
(Aoki et al., 2007). KHV was highly virulent and
naturally cause mortality for more than 80%, both in
koi and carp, less than a week in the subtropic area
(Perelberg et al., 2003). KHV outbreaks typically
occur in spring and autumn, but not when the
temperatures were high as in the summer or lower
as in the winter (Yuasa et al., 2008).
Various efforts have continuously been made to
control the KHV diseases and one of the methods is
enhancing the immune system using the DNA
vaccine. DNA vaccines constitute a third generation
vaccines after conventional, and protein recombinant
vaccine. The vaccine will protect the organism against
disease by injecting pure naked DNA to induce the
immune response (Lorenzen & LaPatra, 2005; Nuryati
et al., 2010a). The DNA vaccine is in the form of
plasmid containing a promoter and specific gene
encoding a protective antigen protein of the desired
pathogen (Kurath, 2008).
There are two candidate DNA vaccines for KHV
that have been constructed in our laboratory, namely
glycoprotein 11 (GP-11) and GP-25. GP-11 has immu-
nogenic properties of 81 ORF KHV virus (Zhou et al.,
2014). GP-11 DNA vaccine is regulated by Japanese
flounder keratin promoter (Alimuddin et al., un-
published). Keratin is an active promoter in several
of known tissues (Yazawa et al., 2005). The efficacy
of GP-11 DNA vaccine remains to test, while GP-25
vaccine efficacy test have been conducted by Nuryati
et al. (2010a). Relative percent survival of GP-25
vaccinated common carp is ranging from 60.7% to
96.67%, and therefore it is considered as an effective
vaccine against KHV. GP-25 is controlled by -actin
promoter of Japanese medaka fish. This study aimed
to test the efficacy of GP-11 KHV DNA vaccines on
koi and compared to GP-25 KHV DNA vaccine.
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MATERIALS AND METHODS
Experimental Fish
Three month old koi (Cyprinus carpio
haematopterus) of 15 fish/groups/aquarium at average
weight of 18-20 g were used as experimental fish.
They were obtained from Main Center of Freshwater
Aquaculture in Sukabumi, West Java. Screening of fish
health was performed during acclimatization period
and confirmed free from KHV based on polymerase
chain reaction (PCR) analysis. Fish were acclimatized
for two weeks in the aquarium equipped with aera-
tion system. Fish were fed with the commercial feed
(28% protein content) at satiation twice a day.
Multiplication of GP-11 KHV DNA Vaccine
The Escherichia coli DH5á strain that containing the
GP-11 DNA plasmid was cultured in the 2xYT solid
medium overnight at 37°C. The E. coli colonies were
transferred to 2xYT liquid medium and incubated in
incubation shaker (200 rpm) at 37°C for 17-20 hours.
Bacteria pellet were harvested by centrifugation for
five minutes at 13,000 rpm. GP-11 plasmid was iso-
lated using plasmid Prep Mini Spin Kit (GE Healthcare,
UK) following the instructional protocol. Plasmid were
resuspended with ion exchange water (IEW) and
stored at -20°C until it would be used for vaccina-
tion.
Vaccination and Fish Maintenance Post
Vaccination
Vaccination was performed by intramuscular in-
jection of GP-11 and GP-25 KHV DNA vaccines. The
use of GP-25 KHV DNA vaccine was intended as a
comparative control. The dose for the vaccination
referred to Nuryati et al. (2010a) and each group was
designed with triplicates (Table 1).
Water quality was maintained through water
exchange as much as 50% per day. Fish were fed at
satiation with the commercial feed contain 28% pro-
tein content twice a day. During the rearing period,
water quality i.e. dissolved oxygen, pH, and total
ammonium nitrogen (TAN) were measured at the
beginning, middle, and at the end of the study, whilst
temperature was measured daily.
Analysis of GP-11 mRNA Expression
The analysis of mRNA expression was performed
at 24 hours, 14 days, and 28 days post vaccination.
Total RNA was extracted from the kidneys using
RNeasy Mini Kit (Qiagen, USA). Synthesis of cDNA
was carried by producing master mix (High Capacity
cDNA Reverse Transcription Kit, Applied Biosystems,
USA) according to number of the sample. The master
mix was then added into each 200 L microtube as
well as 10 L/tube, followed by RNA template inser-
tion and then homogenized. Sample was then incu-
bated into four steps of mRNA analysis temperature
condition (step 1: 25°C at 10 minutes; step 2: 37°C at
120 minutes; step 3: 85°C at five minutes; dan step 4:
4°C at 30 second).
GP-11 mRNA expression analysis was conducted
by using RT-PCR method. Primers used for PCR am-
plification were F-81 (F: 5’-TTA CCG GTA TGG CCT
CCA CTT CAA CCG CT-3’) and R-81 (R: 5’-TAG AGA
TCG TCC CAG TCC TT GTT TAG-3’). The amplifica-
tion process was carried out with initial tempera-
ture of 94°C for three minutes; 94°C for 30 seconds;
59°C for 20 seconds; 72°C for 30 seconds by 45 cycles;
then the final extention of 72°C for three minutes.
The PCR detection was performed by using 1.5% aga-
rose gel electrophoresis (TopVision® Agarose, USA),
and the size of amplification was predicted using
100-bp DNA ladder (Vivantis, USA).
Challenge Test
Ten percent suspension of gill from KHV-infected
fish were prepared and titrated for virus isolation.
Fish titration was done in koi fish. The challenged
test was performed by intramuscular (IM) injection
of virus suspension 0.1 mL/fish (103 FID
50
) to all groups.
As a negative control, koi without vaccination was
injected with PBS, while the positive control with-
out vaccination was injected with 0.1 mL KHV fil-
trate. Each group was performed with triplicates.
Challenged test was carried out on 42-day post vacci-
nation (dpv), and observed for next 30 days on the
KHV permissive temperature. The dead fish were
taken and analyzed by PCR to confirm the mortality
was caused by KHV infection.
ELISA Test
The serum of fish from each groups were collected
on 0, 7, 14, 21, 28, 35, 42, 56, 63, 70, and 77 dpv, fish
in each group were taken randomly for the prepara-
tion of blood serum. Blood serum was obtained after
centrifugation at 3,500 rpm, 4°C for 10 minutes and
stored at -20°C until ready to be used. The present
of antibody anti-KHV were tested by indirect ELISA
using KHV virus for coated plate. Antigen KHV were
diluted 1:160 using a coating buffer (0:05 M carbon-
ate-bicarbonate pH 9.6) to final concentration of an-
tigen of 5 g/mL. The diluted-antigen was then in-
serted into each microplate well as much as 100 L/
well and incubated at 4°C overnight. Plate was then
washed five times using 300 L PBS-T (PBS pH 7.4 +
of 0.05% Tween-20) for each well. The plate was
blocked with100 L/ well of 5% skim milk PBS solu-
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tion and incubated at 37°C for one hour. Plate was
then washed with the same method as the previous
step. Serum samples were diluted to 1:100 and then
added 100 ìL to each well and incubated at 37°C for
one hour. Plate was washed with the same method
as the previous step. Anti-IgG of koi (produced by
our laboratory) derived from rabbit diluted to 1:200
was added as much as 100 L in each well and incu-
bated at 37°C for one hour and the plate was washed
again. Anti-rabbit IgG which has been conjugated with
Horse Reddish Peroxydase (HRP) diluted to 1:10,000
and then added 100 L to each well and incubated at
37°C for one hour. Plate was then washed with the
same method as the previous step. As a substrat One-
Step Ultra TMB-ELISA was added 100 L to each well
and let stand for 15-20 minutes. The reaction was
stopped by adding 50 L of H
2
SO
4
 2M and optical
density (OD) was measured at 450 nm. The cut of
value (CV) in this test was obtained by the equation:
CV= negative control mean + standard deviation
Statistical Analysis
Survival (SR), relative percent survival (RPS), total
leukocytes (TL), leukocyte differential count (DL),
phagocytic activity (PA), and antibody titer were ana-
lyzed using ANOVA test with SPSS ver.19 at a signifi-
cant level of 0.05. Significant differences between
groups were determined using a post-hoc Duncan
test. Clinical signs, interpretation of PCR results and
mRNA expression were analyzed descriptively.
RESULTS
Survival
Survival of fish after the challenge test was shown
in Table 2. Survival of vaccinated fish after challenge
test with KHV showed that the GP-11 7.5 g/100 L
(93.33%), GP-11 12.5 g/100 L (83.33%), and GP-25
12.5 g/100 L (86.67%) were significantly higher
(P<0.05) compared to C+ (33.33 %).
Table 1. Vaccine dosage groups
Groups Vaccine dosage (µg/100 µL) DNA vaccine Challenge test
Negative control (C-) - - Without challenge test
Positive control (C+) - - Challenged
1 2.5 GP-11 Challenged
2 7.5 GP-11 Challenged
3 12.5 GP-11 Challenged
4 12.5 GP-25 Challenged
Table 2. Survival (SR) and relative percent survival (RPS)
of koi challenged with KHV
Groups Survival rate (%) RPS (%)
C- 100.0 ± 0.0d -
C+ 33.3 ± 5.8a -
1 50.0 ± 10.0b 24.6±15.8a
2 93.3 ± 11.6cd 90.5 ± 16.5b
3 83.3 ± 5.8c 75.4 ± 6.8b
4 86.7 ± 5.8cd 80.2 ± 7.6b
C- = unvaccinated and unchallenged fish as negative control, C+=
unvaccinated and challenged with KHV as positive control, 1=
vaccinated group at dose of 2.5 g/100 L of GP-11; 2=
vaccinated group at dose of 7.5 g/100 L of GP-11; 3=
vaccinated group at dose of 12.5 g/100 L of GP-11; 4=
vaccinated group at dose of 12.5 g/100 L of GP-25. Different
superscript letters in the same column indicate significant
differences (P<0.05)
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Clinical Signs
Clinical signs was firstly noted in the group of C+
and group 1 (GP-11 2.5 g/100 L) on day seven. The
primary clinical signs were decreased of appetite, fish
swim on the surface and difficult to breath, irregular
swimming and loss of balance, hemorrhage, and
necrosis in the skin and gill (Figure 1 B-D).
GP Expression
The GP-11 gene expression was detected in the
kidney of all vaccinated fish with doses of 2.5 g/100
L (1), 7.5 g/100 L (2), and 12.5 g/100 L (3)
(Figure 2A). Meanwhile, the expression of -actin was
detected in all test samples, including control with-
out any vaccination (Figure 2B).
Phagocytic Activity (PA)
The observations of phagocytic activity (PA) in the
blood of all groups showed fluctuating results. In
general, the phagocytic activity value of vaccinated
fish were higher compared to control, both during
the rearing period after vaccination and challenge test
(Figure 3).
Figure 1. The clinical signs of fish infected with KHV. Healthy
fish (A), hemorrhage (B), damaged fins (C), and
necrosis (D)
Figure 2. The GP-11 gene expression in the vaccinated koi (A), and PCR products by
using -actin primer (B), 100 bp DNA ladder (M), vaccine dose of 7.5 g/100
L in 24 h post vaccination (1), vaccine dose of 12.5 g/100 L in 24 hour
post vaccination (2), vaccine dose of 2.5 g/100 L in 14 day post vaccina-
tion (3), vaccine dose of 7.5 g/100 L in 14 day post vaccination (4),
vaccine dose of 2.5 g/100 L in 28 day post vaccination (5), vaccine dose of
7.5 g/100 L in 28 day post vaccination (6), control fish without vaccina-
tion (7), negative control without DNA template (8), and GP-11 plasmid as
template (9). The arrows indicate the target of PCR amplification product
(200 bp)
M     1     2      3     4      5     6      7     8
 
 
 
 
 
 
 
A
B
M     1      2     3     4      5     6      7     8     9
200 bp
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Number of Leukocytes
The number of leukocytes in this experiment were
increased in all groups, started from initial day of
observation until 42 dpv and generally decreased in
all groups at 7 dpi (56 dpv) (Figure 4).
Antibody Titer
Antibody anti-KHV were able to detect on day 7
to 14 post vaccination, but on day 21 to 28 the titer
was low. It showed that on day 21 to 28 the absor-
bance were under CV. The antibody titer was increased
Figure 3. The phagocytic activity during the rearing period after vaccination and challenge test with KHV.
The C- refer to negative control, C+ refer to positive control, GP-11 2.5 g/100 L (1), GP-11
7.5 g/100 L (2), GP-11 12.5 g/100 L (3), and GP-25 12.5 g/100 L (4). The arrow indicates
the injection time for KHV challenge test
Figure 4. Leukocytes count during the rearing period after vaccination and post infection with KHV. The
C- refer to negative control, C+ refer to positive control, GP-11 2.5 g/100 L (1), GP-11 7.5
g/100 L (2), GP-11 12.5 g/100 L (3), and GP-25 12.5 g/100 L (4). The arrow indicates the
injection time for KHV challenge test
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on day 35 to 42 post vaccination and decrase again
on day 56 (day 7 post infection). The antibody showed
a positive value on day 70 to 77.
DISCUSSION
High survival of vaccinated fish showed that DNA
vaccines were able to be transcribed and translated
into an immunogenic protein (glycoprotein KHV). The
GP is recognized as the KHV antigen which able to
induced specific antibody that then able to protect
fish from KHV infection. This result expresses that
injected DNA in the host cells will be transcribed and
translated into proteins that were identical to the
wild-type protein expressed by a virus that is capable
of inducing immune responses as describe by Donnelly
et al. (1997). RPS value in groups-2 (90.48%), 3 (75.40%),
and 4 (80.16%) have met the effective range for the
protection, which is more than 50% (Triyanto et al.,
1997). Vaccination using lower doses, 2.5 mg/100 mL,
was unable to induce protective antibody as it shown
in the higher mortality rate of about 75% after chal-
lenge test.
The use of GP-11 and GP-25 DNA vaccines in this
study had the same effectiveness in relation to the
protection against KHV infection. However, the lower
dose of GP-11 DNA vaccine (7.5 mg/100 mL) was
enough to provide a protection against KHV infec-
tion compared to GP-25 (12.5 g/100 mL). Therefore,
in term of production cost, GP-11 DNA vaccine is
more economical than GP-25.
Fish infected with KHV after the challenge test
showed the prime clinical signs such as decreased of
appetite, fish swim on the surface and difficult to
breath, irregular swimming and loss of balance,
hemorrhage and necrosis in the skin and gill. The
clinical sign occurs due to the damage of epithelial
cells of the skin and other cells due to the presence
of KHV infection. This is consistent with the state-
ment of Taukhid et al. (2005), that the surface of the
fish’s body began rough caused by the loss of mucus.
This was due to the damage of epithelial cells lead to
the declining of mucus production. In addition, fish
also showed the rupture of blood vessels that cause
bleeding (hemorrhage) (Figure 1B), damage to the fins
(Figure 1C) and cell death (necrosis) in the gills
(Figure 1D). Hemorrhage and necrosis in the gills
cause the systemic damage to the organ (Pikarsky et
al., 2004). However, some infection fish had no evi-
dence of skin ulcer or hemorrhages (Hedrick et al.,
2000). Fish showing these clinical symptoms suggest
the occurrence of acute infection and generally caused
mortality more than 80%, both in koi and common
carp in less than a week (Perelberg et al., 2003).
The transcription and translation mechanism of
DNA vaccine in the host cells was proved through
mRNA analysis of DNA vaccine GP-11 at 24 and 14
Figure 5. Titer antibodies response of koi during the rearing period after vacci-
nation and challenge test. The C- refer to negative control, C+ refer to
positive control, GP-11 2.5 g/100 L (1), GP-11 7.5 g/100 L (2),
GP-11 12.5 g/100 L (3), and GP-25 12.5 µg/100 L (4); the arrow
indicatesthe injection time for KHV challenge test
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hour post vaccination, respectively. The presence of
GP-11 expression showed that the keratin promoter
of Japanese flounder Paralichthys olivaceus could be
recognized by trans-acting of koi. GP-11 gene
expression in each groups could be observed in dif-
ferent times (Figure 2A). However, those expressions
of DNA vaccines in the short-term is most likely
enough to evoke an immune response both cellular
and humoral immunity to provide protection against
KHV infection. The immune response initiated by
antigen precenting cells (APC) containing dendritic
cells and macrophages that expresses the glycopro-
tein from the vaccine. APC containing cytosolic
encoding pDNA may transcribe and translate the
transgene and thereby produce immunogenic pro-
teins, mimicking an infection of an intracellular (cy-
tosolic) pathogen and allow presentation of the for-
eign antigen peptide by major histocompatibility
complex (MHC) class I on the surface of the APC.
Antigen presenting cells can also take up soluble an-
tigens released from another transgene-producing cell
(e.g. a myocyte), process it and present the peptide
on MHC class II molecules at the cell surface. The
T-cell receptor (TCR) may recognise these peptides
presented on the MHC class I and MHC class II, which
stimulate a CD8 + T-cell (cytotoxic T cell) and a CD4
+ T-cell (helper T cell) response, respectively
(Tonheim et al., 2008). Cytotoxic T cells would de-
stroyed intracellular microorganisms by identifying
microorganisms presented by MHC class I on the cell
surface of macrophages. Cytotoxic T cells also
produce gamma-interferon which is capable of
preventing the spread of microorganisms into another
cell. Helper T cells will recognize the micro -
organisms presented by MHC class II on the cell
surface of macrophages. The signal induces the
lymphocytes to produce various types of
lymphokines. The binding of MHC class II by helper T
cells will give a signal that B lymphocytes to prolif-
eration into plasma cells and differentiation to make
antibodies (Kresno, 2001).
Gene expression on host cell due to GP-11 DNA
vaccination is strong to induce either hummoral
immune response orcelluler immune response. Non-
specific immune response mechanism in this study
was demonstrated by phagocytic activity value. The
result showed that vaccinated groups demonstrated
the higher value compared to control, either in pe-
riod post vaccination or after challenge (Figure 3).
Increasing of phagocytic activity was initially observed
at 7 to 28 day post vaccination (dpv). Significant de-
clines occurred in 56 dpv (seven day postinfection),
this related to the KHV challenge test process. De-
creasing of phagocytic activity that observed due to
cellular immune activity in the circulatory system.
Phagocytic cells was then transfered and performed
it activities on the site of infection, so that the
leukocytes cells that performed phagocytic activity
in the blood vessels become lower (Nuryati et al.,
2010a). Increasing and decreasing pattern of phago-
cytic activity value related to cellular immune
response. Tizard (1988) stated that the increasing pat-
tern of phagocytic activity value reflects the function
of total leukocytes and it cells differentiation (lym-
phocytes, monocytes, neutrophils, and thrombocytes)
to antigens in the body.
Other cellular immune response observed in this
study was total leukocyte cells. Total leukocyte cells
observed in this study showed that in all groups the
value was increased until 42 dpv (Figure 4). This con-
dition caused by the formation of glycoprotein from
GP-11 DNA injected into the body of the fish and
recognized as an antigen. Fish body responded to
the GP-11 glycoprotein as an antigen by increasing
the production of leukocytes. The increase number
of leukocytes is the response of fish immune system
to develop the cellular immune response (Kresno,
2001). The number of lymphocyte during the rearing
period also increased. Lymphocytes have an impor-
tant role, especially in the provision of immune sub-
stances by recognizing the antigens via specific re-
ceptors on the cell membrane (Mundriyanto et al.,
2002). The increase in the number of lymphocytes in
these observations was inversely proportional to the
number of monocytes and neutrophils that were de-
creased during the rearing period after the vaccina-
tion. This is more due to the absence of infection
into the body so that the monocytes and neutrophils
have not been fully activated. This condition was also
observed in the thrombocytes during the rearing
period after vaccination.
Number of leukocytes was generally decreased in
all groups at 7 dpi (56 dpv). Declining number of
leukocytes was caused by the immune system to over-
come the infection caused by KHV. The declining trend
of leukocytes in the treated fish and positive control
fish after challenge test were allegedly active and out
from the blood vessels leading to the infected tissue
(Nuryati et al., 2010b). This condition was also ob-
served in the declining trend of lymphocytes due to
the withdrawn process of lymphocytes from the cir-
culation and competed in the infected tissue.
However, the number of monocytes and neutrophils
increased after the infection. Increasing number of
monocytes and neutrophils cell mainly caused by KHV
infection in the body so that the cells become acti-
vated. Monocytes and neutrophils were effector cells
that activated by the presence of pathogen microor-
ganisms and have a role in the inflammation at the
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early period of infection and alien destruction (Kollner
et al., 2002; Clauss et al., 2008). This condition also
lead to the increasing number of thrombocytes after
infection. Increasing number of thrombocytes mainly
due to the damaged (sores) caused by KHV infection
that lead to the blood clotting to prevent further
bleeding (hemorrhage) (Clauss et al., 2008).
One of the unique features of DNA vaccine is their
ability to stimulate both cellular and humoral immune
response (Tonheim et al., 2008). Specific antibody
formed is important parameter of vaccination effect.
The observations of antibody titer of all groups
showed fluctuating results. Antibody titer showed a
positive value at 7 to 14 dpv. However, the absor-
bance values at 21 to 28 dpv were decline. The in-
crease in the absorbance was observed again at 35
and 42 dpv, each only occur in groups 2 and 4. This
relates to the results of the GP-11 gene expression
in fish body, where the GP-11 gene expression in each
groups was actively observed at different times. GP-
11 gene expression in relation to the antibody
response closely associated with promoter activity
(Alimuddin et al., 2009).
Antibody titer response after the challenge test
was decline at 7 dpi (56 dpv). This decrease relates
to the process of KHV infection, where the
antibodies in the blood circulation were used to neu-
tralize the circulating virus so that the amount of
immunoglobulin (Ig) in circulation declined. However,
at the end of challenge test (63-77 dpv), in the treated
fish, antibody titer generally increased to 70-77 dpv.
The increase in titer antibodies after the challenge
test closely related to the mortality pattern, the
vaccinated test fish had higher survival compared to
the controls. The low mortality of vaccinated fish
during the challenge associated with the ability to
neutralize the KHV virus by antibodies. Neutraliza-
tion is described as the loss of infectivity of the vi-
rus due to the binding of the antibodies to the virus
particle (Dimmock, 1995). The neutralization mecha-
nisms perform if there is enough antibody propor-
tion of the infectious site, which inhibit the attach-
ment virus to the host. Attaching the moleculs to
the virus envelope could from the infected cells neu-
tralization process. The attaching process will cause
the clearance of virus by the antibody through anti-
body-dependent celluler cytotoxicity (ADCC) or complement-
dependent cytotoxicity (CDC) which inhibits virus repli-
cation within cells, virus release of the infected cells,
and even virus transmission between cells (Burton,
2002).
CONCLUSION
The application of 7.5 g/100 L of GP-11 DNA
vaccines has an equal efficacy with 12.5 g/100 L
GP-25 related to the immune response activity against
KHV infection. This was supported by cellular and hu-
moral immune responses that most likely works syn-
ergically to improve the survival of vaccinated fish.
Thus, GP-11 DNA vaccine was eligible to used to pre-
vent high mortality of koi against KHV injection.
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